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World Diabetes Day (every year on November 14) is a good opportunity to emphasis on diabetes and its related aspects and correlation with other health 
conditions as well as available programs and services for diabetic 
patients (1-3). Different topics have been discussed in the past 
years have been diabetes and lifestyle, diabetes, human rights, 
the costs of diabetes (3-5). In addition, other topics have been 
focused such as diabetes and foot care in 2005, diabetes in the 
disadvantaged and the vulnerable in 2006, diabetes in children 
and adolescents in 2007 and 2008 and diabetes education and 
prevention is the world diabetes day theme for the period 2009-
2013 (1-6). Furthermore, due to its importance, pathological 
classification of diabetic nephropathy has been published by 
research committee of the renal pathology society in 2010 which 
in turn could increase the attentions to control and prevention 
of diabetic kidney disease. Increased blood pressure levels, 
hyperglycemia and genetic predisposition may be the main 
risk factors for the development of diabetic kidney disease. 
Moreover, diabetic nephropathy is the most common cause of 
chronic kidney disease which is an international health threat 
with not fully appreciated mechanism of this health condition 
(7). Diabetic nephropathy could affect about 40% of type 1 and 
type 2 diabetic patients, increases the risk of death, especially 
heart conditions. There is still no uniform classification for 
diabetic nephropathy (7-9). However, it can be explained by 
increased urinary albumin excretion (UAE) in the absence 
of other renal diseases. Indeed, diabetic nephropathy may 
categorized into stages of: micro-albuminuria (UAE>20 μg/
min and ≤199 μg/min) and macro-albuminuria (UAE ≥200 μg/
min). Therefore, in type 2 diabetic patients, screening should 
be done at the diagnosis time as well as the following years 
after diagnosis (6-8). To achieve the best metabolic control 
(HbA1c <7%), controlling blood pressure (<130/80 mmHg 
or <125/75 mmHg if proteinuria >1.0 g/day and increased 
serum creatinine), using medications with blockade effect on 
angiotensin II, and controlling hyperlipidemia are the most 
effective programs to prevent the progression of albuminuria, 
by making delay in the development of diabetic kidney 
disease in patients with type 1 and type 2 diabetes. However 
recently, there was much attention towards better knowledge of 
morphologic lesions in diabetic nephropathy and proposing a 
classification for diabetic nephropathy to better control of this 
disease. 
Conclusion
Classification of diabetic nephropathy may lead to a better 
communication and collaboration between renal pathologists 
and clinicians, to prepare a logistic structure for prognostic and 
interventional researches, and to improve clinical management 
and improved efficiency. In addition, the application of 
mentioned pathological classification of diabetic nephropathy 
may increase the diagnosis rate and raise the attention towards 
tubular and interstitial injury in diabetic nephropathy, early 
diagnosis and treatment of diabetic nephropathy (7-12). 
Implication for health policy/practice/research/medical education:
November 14, world diabetes day is the best opportunity to discuss about different aspects of diabetes 
mellitus because the incidence of type 2 diabetes mellitus is increasing rapidly. In addition, diabetic 
nephropathy is a main cause of renal disease. In fact, many more people will be at risk of type 2 diabetes 
mellitus as well as the fact that about 470 million people globally will be pre-diabetics. Based on the 
definition of World Health Organization (WHO), people with pre-diabetes have fasting blood sugar 
(FBS) concentrations between 110 mg/dl and 126 mg/dl or between 101 mg/dl and 124 mg/dl, based on 
the definition of American Diabetes Association.
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